Emotional dysfunction in Parkinson's disease
- PMID: 21876260
- PMCID: PMC3177157
- DOI: 10.3233/BEN-2011-0329
Emotional dysfunction in Parkinson's disease
Abstract
In addition to motor symptomatology, idiopathic Parkinson's disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional dysfunction in Parkinson patients suggest abnormalities involving mesolimbic and mesocortical dopaminergic pathways. There is also evidence suggesting that the interaction between serotonin and dopamine systems is important in the understanding and treatment of mood disorders in Parkinson's disease. In this review we discuss the neuropsychiatric abnormalities that accompany Parkinson's disease and describe their neuropsychological, neuropharmacologic, and neuroimaging concomitants.
Similar articles
-
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17. Brain. 2010. PMID: 20237128 Clinical Trial.
-
Validation of diagnostic criteria for apathy in Parkinson's disease.Parkinsonism Relat Disord. 2010 Dec;16(10):656-60. doi: 10.1016/j.parkreldis.2010.08.015. Epub 2010 Sep 22. Parkinsonism Relat Disord. 2010. PMID: 20864380
-
Differential contributions of depression, apathy, and anxiety to neuropsychological performance in Parkinson's disease versus essential tremor.J Clin Exp Neuropsychol. 2022 Nov;44(9):651-664. doi: 10.1080/13803395.2022.2157796. Epub 2023 Jan 4. J Clin Exp Neuropsychol. 2022. PMID: 36600515 Free PMC article.
-
Psychiatric Manifestation in Patients with Parkinson's Disease.J Korean Med Sci. 2018 Nov 1;33(47):e300. doi: 10.3346/jkms.2018.33.e300. eCollection 2018 Nov 19. J Korean Med Sci. 2018. PMID: 30450025 Free PMC article. Review.
-
Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.Mol Med. 2021 Apr 15;27(1):40. doi: 10.1186/s10020-021-00301-7. Mol Med. 2021. PMID: 33858320 Free PMC article. Review.
Cited by
-
Sleep disturbances in Parkinson's disease patients and management options.Nat Sci Sleep. 2011 Dec 1;3:125-33. doi: 10.2147/NSS.S18897. Print 2011. Nat Sci Sleep. 2011. PMID: 23616723 Free PMC article.
-
Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.J Neurol. 2018 Aug;265(8):1764-1771. doi: 10.1007/s00415-018-8913-9. Epub 2018 May 26. J Neurol. 2018. PMID: 29804147
-
Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.Sci Rep. 2017 Mar 22;7:44989. doi: 10.1038/srep44989. Sci Rep. 2017. PMID: 28327638 Free PMC article.
-
Long-Term Supplementation with Beta Serum Concentrate (BSC), a Complex of Milk Lipids, during Post-Natal Brain Development Improves Memory in Rats.Nutrients. 2015 Jun 5;7(6):4526-41. doi: 10.3390/nu7064526. Nutrients. 2015. PMID: 26056919 Free PMC article.
-
Premotor biomarkers for Parkinson's disease - a promising direction of research.Transl Neurodegener. 2012 May 31;1(1):11. doi: 10.1186/2047-9158-1-11. Transl Neurodegener. 2012. PMID: 23211054 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical